This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Advances in Drug Repositioning

Advances in Drug Repositioning

Tuesday, December 3, 2019, 8:30 AM - 6:00 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Repositioning of existing therapeutics to treat diseases beyond those originally intended has benefited a growing number of unmet patients’ needs. Early contributions in this field were largely serendipitous in nature, typically exploiting direct observations of desirable side effects in patients.  Over time tools and tactics have evolved to  incorporate  insights gleaned from artificial intelligence platforms suggesting previously unappreciated roles of the intended mechanism, target or pathway in other disease contexts.  This symposium will bring together scientists from academia, industry and government to discuss best practices for rational drug repositioning with a focus on computational methods and big data mining, enhanced levels of open collaboration, and initiatives seeking to address rare and neglected diseases.

Call for Abstracts

Abstract submissions are invited for a poster session. Top poster abstracts will be selected for short talks. For complete submission instructions, please visit our online portal. The deadline for abstract submission is October 4, 2019.

Registration

Member
By 10/22/2019
$90
After 10/22/2019
$130
Nonmember Academia, Faculty, etc.
By 10/22/2019
$180
After 10/22/2019
$260
Nonmember Corporate, Other
By 10/22/2019
$250
After 10/22/2019
$350
Nonmember Not for Profit
By 10/22/2019
$180
After 10/22/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 10/22/2019
$100
After 10/22/2019
$145
Member Student, Post-Doc, Fellow
By 10/22/2019
$50
After 10/22/2019
$70
Earlybird Registration:
118
days
left
Deadline:
100
days
left

Scientific Organizing Committee

Pamela Hill, MS

AstraZeneca

Bobbie-Ann Mount, PhD

National Center for Advancing Translational Sciences

Sara Donnelly, PhD

The New York Academy of Sciences

Sonya Dougal, PhD

The New York Academy of Sciences

Keynote Speaker

Matthew Might, PhD
Matthew Might, PhD

University of Alabama at Birmingham

Speakers

Pamela Hill, MS

AstraZeneca

Heather Stone, MPH

US Food and Drug Administration (FDA)

Sean Ekins, PhD, DSc

Collaborations Pharmaceuticals

Andrew Reaume, PhD, MBA

Melior Discovery

Clemens Scherzer, MD

Harvard Medical School and Brigham & Women’s Hospital

Bobbie-Ann Mount, PhD

National Center for Advancing Translational Sciences

Alessandro Lagana, PhD

Icahn School of Medicine at Mount Sinai